{"id":"https://openalex.org/W2166135044","doi":"https://doi.org/10.3109/15563650.2014.983239","title":"Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45","display_name":"Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45","alternate_titles":[],"publication_year":2014,"publication_date":"2014-11-28","ids":{"openalex":"https://openalex.org/W2166135044","doi":"https://doi.org/10.3109/15563650.2014.983239","mag":"2166135044","pmid":"https://pubmed.ncbi.nlm.nih.gov/25430506"},"language":"en","primary_location":{"id":"doi:10.3109/15563650.2014.983239","doi":"https://doi.org/10.3109/15563650.2014.983239","is_oa":false,"landing_page_url":"https://doi.org/10.3109/15563650.2014.983239","pdf_url":null,"source":{"id":"https://openalex.org/S101107869","display_name":"Clinical Toxicology","issn_l":"0009-9309","issn":["0009-9309","1556-3650","1556-9519"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Toxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2166135044"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052209976","display_name":"Sindhu Siddiqi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210113441","display_name":"Kings Health Partners","ror":"https://ror.org/01xcsye48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113441"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sindhu Siddiqi","raw_affiliation_strings":["General Medicine, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Medicine, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078652632","display_name":"Charlotte Verney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210113441","display_name":"Kings Health Partners","ror":"https://ror.org/01xcsye48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113441"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charlotte Verney","raw_affiliation_strings":["General Medicine, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Medicine, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019447625","display_name":"Paul Ivor Dargan","orcid":"https://orcid.org/0000-0002-3433-9622","observed_orcids":["https://orcid.org/0000-0002-3433-9622"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210113441","display_name":"Kings Health Partners","ror":"https://ror.org/01xcsye48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113441"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Dargan","raw_affiliation_strings":["General Medicine, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; Clinical Toxicology, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; King's College London, London, UK","Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","General Medicine, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Medicine, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; Clinical Toxicology, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; King's College London, London, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"General Medicine, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015960673","display_name":"David Michael Wood","orcid":"https://orcid.org/0000-0002-7826-7237","observed_orcids":["https://orcid.org/0000-0002-7826-7237"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]},{"id":"https://openalex.org/I4210113441","display_name":"Kings Health Partners","ror":"https://ror.org/01xcsye48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210113441"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David M. Wood","raw_affiliation_strings":["General Medicine, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; Clinical Toxicology, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; King's College London, London, UK","Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","General Medicine, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Medicine, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; Clinical Toxicology, Guy's and St Thomas\u2019 NHS Foundation Trust, and King's Health Partners, London, UK; King's College London, London, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"General Medicine, Guy's and St Thomas' NHS Foundation Trust, and King's Health Partners, London, UK","institution_ids":["https://openalex.org/I200166805","https://openalex.org/I4210113441"]},{"raw_affiliation_string":"King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5015960673"],"corresponding_institution_ids":["https://openalex.org/I183935753","https://openalex.org/I200166805","https://openalex.org/I4210113441"],"apc_list":null,"apc_paid":null,"fwci":5.584,"has_fulltext":false,"cited_by_count":117,"citation_normalized_percentile":{"value":0.96788618,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"53","issue":"1","first_page":"54","last_page":"59"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/new-psychoactive-substances","display_name":"new psychoactive substances","score":0.984000027179718},{"id":"https://openalex.org/keywords/opioid-like-effects","display_name":"opioid-like effects","score":0.6909999847412109},{"id":"https://openalex.org/keywords/medicine-availability","display_name":"drug availability","score":0.6119999885559082},{"id":"https://openalex.org/keywords/online-drug-sales","display_name":"online drug sales","score":0.7879999876022339},{"id":"https://openalex.org/keywords/acute-toxicity","display_name":"acute toxicity","score":0.7360000014305115},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.6150000095367432},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.8600000143051147},{"id":"https://openalex.org/keywords/heroin-withdrawal","display_name":"heroin withdrawal","score":0.9470000267028809},{"id":"https://openalex.org/keywords/online-discussion-forums","display_name":"online forums","score":0.4699999988079071},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C110875604","wikidata":"https://www.wikidata.org/wiki/Q75","display_name":"The Internet","level":2,"score":0.7536400556564331},{"id":"https://openalex.org/C55282118","wikidata":"https://www.wikidata.org/wiki/Q252683","display_name":"Snapshot (computer storage)","level":2,"score":0.4829792082309723},{"id":"https://openalex.org/C3019607171","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychoactive substance","level":2,"score":0.47861355543136597},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4171856939792633},{"id":"https://openalex.org/C33070731","wikidata":"https://www.wikidata.org/wiki/Q7218","display_name":"Toxicology","level":1,"score":0.41471225023269653},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.40562278032302856},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.3425416946411133},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3173021078109741},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2299998700618744},{"id":"https://openalex.org/C136764020","wikidata":"https://www.wikidata.org/wiki/Q466","display_name":"World Wide Web","level":1,"score":0.17598098516464233},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13747677206993103},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/15563650.2014.983239","doi":"https://doi.org/10.3109/15563650.2014.983239","is_oa":false,"landing_page_url":"https://doi.org/10.3109/15563650.2014.983239","pdf_url":null,"source":{"id":"https://openalex.org/S101107869","display_name":"Clinical Toxicology","issn_l":"0009-9309","issn":["0009-9309","1556-3650","1556-9519"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Toxicology","raw_type":"journal-article"},{"id":"pmid:25430506","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25430506","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical toxicology (Philadelphia, Pa.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1843378687","https://openalex.org/W1985009784","https://openalex.org/W1999091569","https://openalex.org/W2007975359","https://openalex.org/W2009775290","https://openalex.org/W2025956558","https://openalex.org/W2048304068","https://openalex.org/W2057029134","https://openalex.org/W2060101478","https://openalex.org/W2061754253","https://openalex.org/W2066735060","https://openalex.org/W2075127763","https://openalex.org/W2090296817","https://openalex.org/W2113396762","https://openalex.org/W2118425345","https://openalex.org/W2138516303","https://openalex.org/W2145358857","https://openalex.org/W2145462275","https://openalex.org/W2163137476","https://openalex.org/W2163987711","https://openalex.org/W2438900064"],"related_works":["https://openalex.org/W2225915160","https://openalex.org/W2118425345","https://openalex.org/W2514843498","https://openalex.org/W4409663694","https://openalex.org/W2914601359","https://openalex.org/W3020153034","https://openalex.org/W1961149692","https://openalex.org/W2611797215","https://openalex.org/W3033130081","https://openalex.org/W2339286762"],"abstract_inverted_index":{"INTRODUCTION:":[0],"1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine":[1],"(MT-45)":[2],"is":[3,13,293],"a":[4,151,161],"novel":[5],"psychoactive":[6],"substance":[7],"available":[8,35,129],"over":[9],"the":[10,41,50,66,91,109,134,172,202,210,227,235,291,296,300],"Internet.":[11],"MT-45":[12,31,138,181,216,244,283],"an":[14,20,78],"opioid-like":[15,228,285],"compound.":[16],"This":[17],"study":[18,118],"provides":[19],"overview":[21],"of":[22,30,34,40,69,74,95,111,113,137,178,204,215,243,251],"availability,":[23,67],"use":[24,70,112,203,259],"and":[25,27,45,55,71,93,192,212,225,250,275,287],"desired":[26,211,286],"unwanted":[28,213,229,288],"effects":[29,73,214,230],"through":[32],"triangulation":[33],"data":[36],"sources.":[37],"METHODS:":[38],"Searches":[39],"published":[42,167,272],"scientific":[43,168,273],"literature":[44,274],"'grey'":[46,276],"information":[47,64,277,292],"sources,":[48,278],"using":[49],"keywords":[51],"'MT":[52],"45',":[53],"'MT-45'":[54],"'1-cyclohexyl-4-(1,2-diphenylethyl)piperazine'":[56],"were":[57,102,240],"undertaken":[58,85],"in":[59,82,86,175,247],"June":[60,99],"2014":[61,88,100],"to":[62,89,104,154,188,201,219,302,307],"identify":[63,105],"on":[65,126,171,196],"prevalence":[68,110],"desired/unwanted":[72],"MT-45.":[75,96,114,124,205],"In":[76,98],"addition":[77],"Internet":[79,116,121,197],"snapshot":[80,117],"survey":[81],"English":[83],"was":[84,128],"May":[87],"determine":[90],"availability":[92],"cost":[94],"RESULTS:":[97],"we":[101,279],"unable":[103],"any":[106],"studies":[107],"reporting":[108,170],"The":[115],"identified":[119,165],"17":[120],"sites":[122],"selling":[123],"Information":[125],"price":[127,136],"from":[130,144],"9":[131],"sites,":[132],"with":[133,140,222,234,263,267],"mean":[135],"decreased":[139],"increasing":[141],"purchase":[142,153],"amounts":[143],"US$57.60":[145],"\u00b1":[146,156],"19.37":[147],"per":[148,158],"gram":[149,159],"for":[150,160],"1-g":[152],"US$3.36":[155],"1.83":[157],"1-kg":[162],"purchase.":[163],"We":[164],"one":[166,183],"paper":[169],"acute":[173],"harms":[174],"nine":[176],"cases":[177],"analytically":[179],"confirmed":[180],"toxicity,":[182],"US":[184],"government":[185],"report":[186],"relating":[187,200],"two":[189],"MT-45-related":[190],"deaths":[191],"20":[193],"user":[194,241],"reports":[195,242],"discussion":[198],"forums":[199],"All":[206],"these":[207],"suggest":[208],"that":[209,226,257,282],"are":[217],"similar":[218,304],"those":[220],"seen":[221,266],"other":[223,268,308],"opioids,":[224],"may":[231,260],"be":[232,261],"reversed":[233],"opioid":[236],"antagonist":[237],"naloxone.":[238],"There":[239],"being":[245],"used":[246],"heroin":[248],"withdrawal":[249],"'withdrawal":[252],"symptoms'":[253],"after":[254],"use,":[255],"suggesting":[256],"long-term":[258],"associated":[262],"dependency":[264],"as":[265],"opioids.":[269,309],"CONCLUSIONS:":[270],"Combining":[271],"have":[280,303],"demonstrated":[281],"has":[284,299],"effects.":[289],"Whilst":[290],"limited":[294],"at":[295],"moment,":[297],"it":[298],"potential":[301],"dependence":[305],"liability":[306]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2166135044","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":71},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
